Skip to content
20-F

Annual Report (Foreign)

BENITEC BIOPHARMA LTD/ADR

0001564590-19-038501

← back to feed
Filed
Oct 30, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2019 · Jun 30, 2019 257.03M sh
Shares Diluted FY 2019 · Jun 30, 2018 210.45M sh
Shares Diluted FY 2019 · Jun 30, 2017 175.43M sh
Shares Outstanding FY 2019 · Jun 30, 2019 257.03M sh
Dividends Paid FY 2019 · Jun 30, 2019 0
Dividends Paid FY 2019 · Jun 30, 2018 0
Operating Cash Flow FY 2019 · Jun 30, 2019 5.86M
Operating Cash Flow FY 2019 · Jun 30, 2018 −9.79M
Operating Cash Flow FY 2019 · Jun 30, 2017 −8.3M
Cash And Equivalents FY 2019 · Jun 30, 2019 22.41M
Cash And Equivalents FY 2019 · Jun 30, 2018 16.09M
Cash And Equivalents FY 2019 · Jun 30, 2017 17.38M
Cash And Equivalents FY 2019 · Jun 30, 2016 18.23M
Stockholders Equity FY 2019 · Jun 30, 2019 23.66M
Stockholders Equity FY 2019 · Jun 30, 2018 18.74M
Stockholders Equity FY 2019 · Jun 30, 2017 21.51M
Stockholders Equity FY 2019 · Jun 30, 2016 18.84M
Current Liabilities FY 2019 · Jun 30, 2019 3.77M
Current Liabilities FY 2019 · Jun 30, 2018 2.55M
Total Liabilities FY 2019 · Jun 30, 2019 3.77M
Total Liabilities FY 2019 · Jun 30, 2018 2.6M
Current Assets FY 2019 · Jun 30, 2019 26.74M
Current Assets FY 2019 · Jun 30, 2018 20.9M
Total Assets FY 2019 · Jun 30, 2019 27.43M
Total Assets FY 2019 · Jun 30, 2018 21.34M
Total Assets FY 2019 · Jun 30, 2017 22.67M
Eps Diluted FY 2019 · Jun 30, 2019 0.02
Eps Diluted FY 2019 · Jun 30, 2018 −0.06
Eps Diluted FY 2019 · Jun 30, 2017 −0.03
Eps Basic FY 2019 · Jun 30, 2019 0.02
Eps Basic FY 2019 · Jun 30, 2018 −0.06
Eps Basic FY 2019 · Jun 30, 2017 −0.03
Rd Expense FY 2019 · Jun 30, 2019 3.1M
Rd Expense FY 2019 · Jun 30, 2018 6.89M
Rd Expense FY 2019 · Jun 30, 2017 6.93M
Net Income FY 2019 · Jun 30, 2019 4.09M
Net Income FY 2019 · Jun 30, 2018 −11.64M
Net Income FY 2019 · Jun 30, 2017 −5.69M
Revenue FY 2019 · Jun 30, 2019 16.16M
Revenue restated FY 2019 · Jun 30, 2018 378K
Revenue restated FY 2019 · Jun 30, 2017 333K